Pet parents want products that actually work.
Our scientific process creates ingredients with best-in-class clinical evidence so brands can deliver on that promise.
Our Integrated R&D Platform
Strain library
Analytical capabilities
Manufacturing
Clinical network
How We Develop Superculture® Ingredients:
Identify Target Biomarkers
First, we deeply understand the biology of the unmet health need we’re targeting, map how natural microbes can uniquely address it, and identify key biomarkers that drive perceptible health benefits.
Develop High-Precision Assays
We then develop novel high-throughput assays to quantify these biomarkers in physiologically relevant conditions, ensuring that our screens yield reproducible and scalable results.
Screen Our Proprietary Biobank
Next, we screen tens of thousands of natural microbes from our proprietary biobank — one of the world's largest and most comprehensive — to identify optimal combinations with exceptional functionalities and verified safety. All strains selected are covered by AAFCO definitions and included on the EU QPS list.
Validate In Clinical Trials
We conduct extensive in vitro studies to ensure formulation compatibility, then prove efficacy through rigorous clinical trials that meet the highest standards.
Scale Production
We optimize manufacturing to reliably deliver Superculture® ingredients at commercial scale while maintaining proven efficacy, safety, and quality.
The Result
The end result is a Superculture® ingredient that targets the root cause of a pet-health need. Each Superculture® ingredient is clinically validated for efficacy, AAFCO-compliant, and proven to delivery the stability, safety, and scalability your products need.